Found: 81
Select item for more details and to access through your institution.
Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 973, doi. 10.1093/cid/ciab598
- By:
- Publication type:
- Article
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e2153, doi. 10.1093/cid/ciaa1219
- By:
- Publication type:
- Article
Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. 1820, doi. 10.1093/cid/ciaa975
- By:
- Publication type:
- Article
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 6, p. 1044, doi. 10.1093/cid/ciy764
- By:
- Publication type:
- Article
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 3, p. 813, doi. 10.1093/infdis/jiae025
- By:
- Publication type:
- Article
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 1, p. 78, doi. 10.1067/mcp.2003.11
- By:
- Publication type:
- Article
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 4, p. 367, doi. 10.1067/mcp.2000.109391
- By:
- Publication type:
- Article
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 19, p. 4334, doi. 10.1093/hmg/dds226
- By:
- Publication type:
- Article
Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1860, doi. 10.1093/cid/civ155
- By:
- Publication type:
- Article
Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1860, doi. 10.1093/cid/civ155
- By:
- Publication type:
- Article
Detection of Nonnucleoside Reverse-Transcriptase Inhibitor—Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 3, p. 421, doi. 10.1086/589867
- By:
- Publication type:
- Article
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv085
- By:
- Publication type:
- Article
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 1, p. 1, doi. 10.1093/ofid/ofu113
- By:
- Publication type:
- Article
Diminished Activity of Ceftizoxime in Comparison to Cefotaxime and Ceftriaxone Against Streptococcus pneumoniae.
- Published in:
- Clinical Infectious Diseases, 1995, v. 20, n. 3, p. 671
- By:
- Publication type:
- Article
Marked Polymorphonuclear Pleocytosis Due to Blastomycotic Meningitis: Case Report and Review.
- Published in:
- Clinical Infectious Diseases, 1994, v. 18, n. 5, p. 816, doi. 10.1093/clinids/18.5.816
- By:
- Publication type:
- Article
Extremely low-coverage sequencing and imputation increases power for genome-wide association studies.
- Published in:
- Nature Genetics, 2012, v. 44, n. 6, p. 631, doi. 10.1038/ng.2283
- By:
- Publication type:
- Article
Pharmacogenomics of antiretroviral therapy.
- Published in:
- Drug Development Research, 2004, v. 62, n. 3, p. 213, doi. 10.1002/ddr.10359
- By:
- Publication type:
- Article
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 11, p. 1081, doi. 10.1007/s00228-009-0725-5
- By:
- Publication type:
- Article
Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, Haiti.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 8, p. 2187, doi. 10.1093/jac/dku088
- By:
- Publication type:
- Article
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 8, p. 2175, doi. 10.1093/jac/dku110
- By:
- Publication type:
- Article
Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent.
- Published in:
- 1996
- By:
- Publication type:
- journal article
The case against anergy testing as a routine adjunct to tuberculin skin testing.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Genetic and Non-Genetic Determinants of Raltegravir Penetration into Cerebrospinal Fluid: A Single Arm Pharmacokinetic Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082672
- By:
- Publication type:
- Article
T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043803
- By:
- Publication type:
- Article
HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006687
- By:
- Publication type:
- Article
Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 6, p. 783
- By:
- Publication type:
- Article
Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 6, p. 779, doi. 10.1086/507101
- By:
- Publication type:
- Article
Reply to Tong et al.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Can Responses to Antiretroviral Therapy Be Improved by Therapeutic Drug Monitoring?
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 8, p. 1197, doi. 10.1086/501464
- By:
- Publication type:
- Article
Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 3, p. 401, doi. 10.1086/499364
- By:
- Publication type:
- Article
Oxidant Stress Is Increased during Treatment of Human Immunodeficiency Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2003, v. 37, n. 12, p. 1711, doi. 10.1086/379776
- By:
- Publication type:
- Article
Can Immune Markers Predict Subsequent Discordance between Immunologic and Virologic Responses to Antiretroviral Therapy? Adult AIDS Clinical Trials Group.
- Published in:
- Clinical Infectious Diseases, 2003, v. 37, n. 4, p. 551
- By:
- Publication type:
- Article
Cryptococcosis in Human Immunodeficiency Virus--Negative Patients in the Era of Effective Azole Therapy.
- Published in:
- Clinical Infectious Diseases, 2001, v. 33, n. 5, p. 1, doi. 10.1086/322597
- By:
- Publication type:
- Article
Recurrent Achromobacter xylosoxidans Bacteremia Associated with Persistent Lymph Node Infection in a Patient with Hyper-Immunoglobulin M Syndrome.
- Published in:
- Clinical Infectious Diseases, 2000, v. 31, n. 5, p. 1183, doi. 10.1086/317461
- By:
- Publication type:
- Article
Factors That Predict Incomplete Virological Response to Protease Inhibitor-Based Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 1999, v. 29, n. 1, p. 75, doi. 10.1086/520185
- By:
- Publication type:
- Article
Editorial Response: Is Adjunctive Corticosteroid Therapy Indicated During Tuberculous Peritonitis?
- Published in:
- Clinical Infectious Diseases, 1998, v. 27, n. 1, p. 57, doi. 10.1086/514628
- By:
- Publication type:
- Article
Proinflammatory Cytokine and Human Immunodeficiency Virus RNA Levels during Early Mycobacterium avium Complex Bacteremia in Advanced AIDS.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 6, p. 1746, doi. 10.1086/517437
- By:
- Publication type:
- Article
Impaired Hepatic Protein Synthesis in AIDS Patients with Low Vitamin A Levels.
- Published in:
- Journal of Infectious Diseases, 1995, v. 172, n. 4, p. 1167
- By:
- Publication type:
- Article
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells.
- Published in:
- PLoS Biology, 2004, v. 2, n. 7, p. 1, doi. 10.1371/journal.pbio.0020198
- By:
- Publication type:
- Article
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells.
- Published in:
- PLoS Biology, 2004, v. 2, n. 7, p. 955, doi. 10.1371/journal.pbio.0020198
- By:
- Publication type:
- Article
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 1, p. 146, doi. 10.1111/bcp.12590
- By:
- Publication type:
- Article
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 4, p. 997, doi. 10.1111/j.1365-2125.2012.04454.x
- By:
- Publication type:
- Article
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.
- Published in:
- Annals of Internal Medicine, 2014, v. 161, n. 7, p. 461, doi. 10.7326/M14-1084
- By:
- Publication type:
- Article
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.
- Published in:
- PLoS Genetics, 2021, v. 17, n. 4, p. 1, doi. 10.1371/journal.pgen.1009464
- By:
- Publication type:
- Article
Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1247, doi. 10.1111/bcp.16009
- By:
- Publication type:
- Article
Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
- Published in:
- International Journal of Epidemiology, 2007, v. 36, n. 2, p. 294, doi. 10.1093/ije/dyl286
- By:
- Publication type:
- Article